Recent Advances in the Chemistry and Therapeutic Evaluation of Naturally Occurring and Synthetic Withanolides
Open Access
- 28 January 2022
- Vol. 27 (3), 886
- https://doi.org/10.3390/molecules27030886
Abstract
Natural products are a major source of biologically active compounds that make promising lead molecules for developing efficacious drug-like molecules. Natural withanolides are found in many flora and fauna, including plants, algae, and corals, that traditionally have shown multiple health benefits and are known for their anti-cancer, anti-inflammatory, anti-bacterial, anti-leishmaniasis, and many other medicinal properties. Structures of these withanolides possess a few reactive sites that can be exploited to design and synthesize more potent and safe analogs. In this review, we discuss the literature evidence related to the medicinal implications, particularly anticancer properties of natural withanolides and their synthetic analogs, and provide perspectives on the translational potential of these promising compounds.Keywords
This publication has 137 references indexed in Scilit:
- Macrophage-Mediated Lymphangiogenesis: The Emerging Role of Macrophages as Lymphatic Endothelial ProgenitorsCancers, 2012
- Cytotoxic Withanolide Constituents of Physalis longifoliaJournal of Natural Products, 2011
- Hallmarks of Cancer: The Next GenerationCell, 2011
- Dinoxin B, a Withanolide from Datura inoxia Leaves with Specific Cytotoxic ActivitiesJournal of Natural Products, 2011
- Thermodynamic and Structural Effects of Macrocyclic Constraints in Protein−Ligand InteractionsACS Medicinal Chemistry Letters, 2010
- Inhibition of NFκB by the natural product Withaferin A in cellular models of Cystic Fibrosis inflammationJournal of Inflammation, 2009
- Discovery of novel isoxazolines as anti-tuberculosis agentsBioorganic & Medicinal Chemistry Letters, 2007
- High-Throughput, High-Sensitivity Analysis of Gene Expression in ArabidopsisPlant Physiology, 2007
- Chronic inflammation: importance of NOD2 and NALP3 in interleukin-1β generationClinical and Experimental Immunology, 2006
- Promoting apoptosis as a strategy for cancer drug discoveryNature Reviews Cancer, 2005